The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting

Martin A. Lee; Stuart Kyle; Robert J. Moots

doi:10.4081/rr.2012.e2

The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting

https://doi.org/10.4081/rr.2012.e2

PDF

Vol. 4 No. 1 (2012)

Submitted: 4 September 2011
Accepted: 15 February 2012

Published: 26 March 2012

Behçet’s disease, inflammatory aortitis, infliximab, endovascular stenting

Abstract Views: 1053

PDF: 326

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Martin A. Lee
martinlee@doctors.org.uk
Rheumatology Department, National Hospital of Rheumatic Diseases, Bath, United Kingdom.
Stuart Kyle Rheumatology Department, North Devon Hospital, Barnstaple, United Kingdom.
Robert J. Moots Clinical Sciences Department, University Hospital Aintree, Liverpool, United Kingdom.

Behçet’s disease is a systemic vasculitis of unknown aetiology that may involve veins and arteries of all sizes. It occurs most commonly in the second or third decades of life and it is characterised by recurrent oral and genital ulceration and chronic relapsing uveitis. We present here a case of Behçet’s disease complicated by an inflammatory aortitis successfully treated with infliximab and endovascular stenting.

Supporting Agencies

Lee, M. A., Kyle, S., & Moots, R. J. (2012). The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting. Rheumatology Reports, 4(1), e2. https://doi.org/10.4081/rr.2012.e2